Technology Networks
| ||
| Permissions | ||
|
Permission to use, copy and distribute documents presented on this World Wide Web site and related graphics is not granted without prior written permission of Technology Networks Ltd
To obtain this permission contact:
In cases where permission is granted, it is done so under the provision that the above copyright notice and this permission notice appear in all copies. All other rights are reserved. |
Finnish Researchers Discover Genes Inhibiting the Spread of Prostate Cancer
Researchers utilize the cell spot micro array technology to study the impacts of all genes in an entire genome in a single experiment. Stabilizing Fanconi Anemia with Antioxidants Fanconi anemia (FA) is a rare genetic disorder which affects one person in 350,000. Scientists Make Groundbreaking Discovery Of Mutation Causing Genetic Disorder In Humans Scientists at A*STAR's Institute of Medical Biology (IMB), in collaboration with doctors and scientists in Jordan, Turkey, Switzerland and USA, have identified the genetic cause of a birth defect known as Hamamy syndrome. Genetic Predictor of Breast Cancer Response to Chemotherapy Gene expression 'signatures' to measure the susceptibility of tumor cells to chemotherapy. Nature Highlights Advancements in Biocatalysis Highlights potential impact on the production of biofuels, renewable chemicals, and pharmaceuticals. New Muscular Dystrophy Treatment Approach Developed Using Human Stem Cells New process makes the production of human muscle cells from stem cells efficient and effective. Revolutionary New Cancer Targeting Technology Described in Nature Medicine Immunocore scientists manage to overcome cancer problem by boosting the ability of cancer-specific TCRs. New Biomarkers Could Offer Vital Clues for Cancer Research European funding for cancer research has led to some interesting results in recent years, says Carl-Johan Ivarsson, CEO at Qlucore. Idera Pharmaceuticals Announces Top-line Results from Phase 2 Clinical Trial IMO-2055 to be used in treatment of patients with advanced head and neck cancer. National Data Center for Cancer Genome Research In the wake of personalized medicine, scientists at the University of California, Santa Cruz, make progress in the management and analysis of large data sets. 
| |
